Status:

COMPLETED

Multiple Ascending Dose Study for LCB01-0371

Lead Sponsor:

LigaChem Biosciences, Inc.

Conditions:

Healthy

Eligibility:

All Genders

20-45 years

Phase:

PHASE1

Brief Summary

Primary * To investigate the safety and tolerability of LCB01-0371 after a multiple oral dose * To investigate the pharmacokinetic characteristics of LCB01-0371 after a multiple oral dose in healthy ...

Detailed Description

* To investigate the PK characteristics of LCB01-0371 after a multiple oral dose * To investigate the safety and tolerability of LCB01-0371 after a multiple oral dose

Eligibility Criteria

Inclusion

  • Health Male between 20 and 45 years of age at the time of screening and a subject with body mass index (BMI) between 19 and 27
  • Medically healthy with no clinically significant screening results through Physical examination, x-ray, 12 lead ECG, Laboratory test
  • Able to donate blood during study period and follow visit.
  • Agree to continue to use a reliable method of birth control until 60 days after study completion.
  • Capable of giving written informed consent and Able to understand and comply with protocol requirements, instructions and protocol-stated restrictions.

Exclusion

  • History of liver, kidney, respiratory, musculoskeletal, endocrinologic, neuropsychiatric, hemato-oncologic, or cardiovascular problem(s).
  • History of gastrointestinal problem which is affect to absorption within 6 months from screening
  • History of hypersensitivity or clinically significant adverse drug reaction(s) to the LCB01-0371, same class of the study drugs (linezolid), or other drugs including aspirin and antibiotics.
  • History drug abuse or positive result of urine drug screening test for amphetamine, methamphetamine, barbiturate, cocaine, opiate, benzodiazepine, cannabinoid, methadone, etc.

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2013

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01842516

Start Date

March 1 2013

End Date

December 1 2013

Last Update

November 17 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Asan Medical Center

Seoul, South Korea